Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations

DSpace/Manakin Repository

Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Jenny, Breanna
dc.date.accessioned 2012-06-03T02:46:07Z
dc.date.issued 2011
dc.identifier.citation Breanna Jenny, Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations (March 2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8822169
dc.description.abstract The FD&C Act and FDA-promulgated regulations work together to bar off-label promotion by pharmaceutical companies. This regulatory framework is often confusing and ambiguous, and FDA “guidance” on the issue has done relatively little to provide clarity. There was a series of trials and appeals in the late 1990s on the constitutionality of such speech restrictions, in which the plaintiff claimed that by prohibiting commercial speech, the First Amendment rights of pharmaceutical companies were being violated. But ultimately confusion perpetuated: although the cases culminated in an injunction against the FDA, the agency reinterpreted their guidance as merely safe harbors that provided no independent prosecutorial basis, rendering the court’s injunction moot. Prosecution of pharmaceutical companies for off-label promotion has increased over the past five years; recently, some pharmaceutical companies have responded by raising anew the First Amendment claims of a decade ago. This time, however, the claims are more narrowly focused, and if the recent oral arguments in front of the Second Circuit are any indication, carry a strong chance of winning. en_US
dash.license LAA
dc.subject General Background>>Constitutional Issues>>Freedom of Speech en_US
dc.subject.other Food and Drug Law en_US
dc.title Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-03T02:46:07Z

Files in this item

Files Size Format View
Jenny, Brenna FDA Law Paper.pdf 321.9Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters